moxifloxacin has been researched along with gsk221149a in 1 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (gsk221149a) | Trials (gsk221149a) | Recent Studies (post-2010) (gsk221149a) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 13 | 4 | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caltabiano, S; Fossler, M; Liu, F; Stier, B | 1 |
1 trial(s) available for moxifloxacin and gsk221149a
Article | Year |
---|---|
Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
Topics: Adult; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Healthy Volunteers; Heart; Heart Rate; Humans; Male; Middle Aged; Moxifloxacin; Piperazines; Receptors, Oxytocin; Young Adult | 2015 |